RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+25.49%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$6.11B
AUM Growth
+$6.11B
(+61%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
31.4%
Top 10 Holdings %
Top 10 Hldgs %
63.75%
Holding
76
New
9
Increased
16
Reduced
14
Closed
12
Top Buys
| 1 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$2.03B |
| 2 |
Vistra
VST
|
$94.6M |
| 3 |
United Airlines
UAL
|
$63.5M |
| 4 |
Treehouse Foods
THS
|
$48M |
| 5 |
Delek US
DK
|
$37.5M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$65.8M |
| 2 |
Dave & Buster's
PLAY
|
$48.8M |
| 3 |
Mr. Cooper
COOP
|
$44.5M |
| 4 |
NCR Voyix
VYX
|
$42.4M |
| 5 |
Collegium Pharmaceutical
COLL
|
$41.9M |
Sector Composition
| 1 | Utilities | 39.64% |
| 2 | Healthcare | 32.73% |
| 3 | Technology | 5.22% |
| 4 | Industrials | 5.16% |
| 5 | Energy | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLN
1
Talen Energy Corporation Common Stock
TLN
$17.3B
| $2.03B | 33.02% | +11,368,614 | New | +$2.03B |
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $288M | 4.7% | 16,005,498 -1,256,243 | -7% | -$22.6M |
|
3
Roivant Sciences
ROIV
$8.15B
| $258M | 4.21% | 22,400,000 -600,000 | -3% | -$6.92M |
|
|
4
Vistra
VST
$64.1B
| $252M | 4.1% | 2,125,000 +797,894 | +60% | +$94.6M |
|
5
Golar LNG
GLNG
$4.48B
| $240M | 3.91% | 6,535,062 | – | – |
|
6
Viatris
VTRS
$12.3B
| $234M | 3.81% | 20,144,365 | – | – |
|
7
QuidelOrtho
QDEL
$1.95B
| $192M | 3.12% | 4,200,000 +554,410 | +15% | +$25.3M |
|
8
BGC Group
BGC
$4.65B
| $156M | 2.54% | 16,972,580 -2,027,420 | -11% | -$18.6M |
|
9
Fluor
FLR
$6.63B
| $133M | 2.16% | 2,783,441 -431,080 | -13% | -$20.6M |
|
10
Liberty Global Class A
LBTYA
$4B
| $117M | 1.9% | 5,530,901 +4,794 | +0.1% | +$101K |
|
11
Arcutis Biotherapeutics
ARQT
$1.86B
| $102M | 1.66% | 10,966,672 +1,150,000 | +12% | +$10.7M |
|
12
Pediatrix Medical
MD
$1.5B
| $95.9M | 1.56% | 8,275,000 +125,000 | +2% | +$1.45M |
|
|
13
Mr. Cooper
COOP
$12.1B
| $95.5M | 1.56% | 1,035,998 -482,775 | -32% | -$44.5M |
|
14
Amneal Pharmaceuticals
AMRX
$3B
| $89.2M | 1.45% | 10,721,778 | – | – |
|
15
ReNew
RNW
$2.76B
| $86.2M | 1.4% | 13,706,102 +200,000 | +1% | +$1.26M |
|
16
Alight
ALIT
$2.05B
| $86.2M | 1.4% | 11,646,679 +3,223,617 | +38% | +$23.9M |
|
17
Dole
DOLE
$1.4B
| $83.8M | 1.36% | 5,141,388 | – | – |
|
18
Liberty Global Class C
LBTYK
$4.07B
| $76.1M | 1.24% | 3,522,428 +11,424 | +0.3% | +$247K |
|
19
Adaptive Biotechnologies
ADPT
$2.01B
| $73.7M | 1.2% | 14,400,000 +400,000 | +3% | +$2.05M |
|
20
Opko Health
OPK
$1.1B
| $72.6M | 1.18% | 48,706,640 +4,284,336 | +10% | +$6.38M |
|
21
Schrodinger
SDGR
$1.44B
| $68.4M | 1.11% | 3,685,503 +555,503 | +18% | +$10.3M |
|
22
Mativ Holdings
MATV
$687M
| $68M | 1.11% | 4,000,000 | – | – |
|
|
PTVE
23
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $65.9M | 1.07% | 5,726,583 | – | – |
|
|
24
United Airlines
UAL
$34B
| $63.5M | 1.03% | +1,112,623 | New | +$63.5M |
|
|
MREO
25
Mereo BioPharma
MREO
$272M
| $62.9M | 1.03% | 15,307,347 | – | – |
|